Literature DB >> 22873504

Moxifloxacin-induced hypoglycemia in a non-diabetic patient.

Divyesh R Mandavia1, Mukund M Virpariya, Tejas K Patel, C B Tripathi.   

Abstract

Hypoglycemia is a rare life threatening adverse drug reaction associated with various fluoroquinolones like ciprofloxacin, gatifloxacin and levofloxacin. Moxifloxacin was considered safe in this regard. Only one case has been reported for moxifloxacin-induced hypoglycemia in a renal failure patient. Here, we are reporting the second case of hypoglycemia due to moxifloxacin without any major co-morbid condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873504     DOI: 10.2174/157488612802715744

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  3 in total

1.  Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial.

Authors:  Abid Ullah; Shujaat Ahmad; Niaz Ali; Shafiq Ur Rahman; Haya Hussain; Saad Alghamdi; Mazen Almehmadi; Anas S Dablool; Azzah M Bannunah; Syeda Hajira Bukhari; Feras Almarshad
Journal:  Antibiotics (Basel)       Date:  2022-01-24

2.  Recurrent episodes of hypoglycemia induced by moxifloxacin.

Authors:  Dinesh Kumar Singal; Amit Mittal; Anukalp Prakash
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

3.  Moxifloxacin Hydrochloride Electrochemical Detection at Gold Nanoparticles Modified Screen-Printed Electrode.

Authors:  M Shehata; Amany M Fekry; Alain Walcarius
Journal:  Sensors (Basel)       Date:  2020-05-14       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.